Daily Mail UK - Leronlimab! New trial will give
Post# of 148152
(Total Views: 640)
Posted On: 05/05/2020 6:27:54 AM
Daily Mail UK - Leronlimab!
New trial will give 75 coronavirus patients experimental HIV and cancer drug this month after two critically ill people in New York treated with the medication recovered Leronlimab is a medication made by biotechnology company CytoDyn and currently in development for treating HIV and cancer
In March, it was given to seven critically ill coronavirus patients in New York
Two of them were well enough to be taken off ventilators in a matter of days, and all but one are improving CytoDyn is now beginning Phase II of its clinical trial with 75 coronavirus patients at the end of May
Here’s how to help people impacted by Covid-19
By MARY KEKATOS SENIOR HEALTH REPORTER and NATALIE RAHHAL ACTING US HEALTH EDITOR FOR DAILYMAIL.COM
PUBLISHED: 23:21 BST, 4 May 2020 | UPDATED: 03:38 BST, 5 May 2020
https://www.dailymail.co.uk/health/article-82...month.html
New trial will give 75 coronavirus patients experimental HIV and cancer drug this month after two critically ill people in New York treated with the medication recovered Leronlimab is a medication made by biotechnology company CytoDyn and currently in development for treating HIV and cancer
In March, it was given to seven critically ill coronavirus patients in New York
Two of them were well enough to be taken off ventilators in a matter of days, and all but one are improving CytoDyn is now beginning Phase II of its clinical trial with 75 coronavirus patients at the end of May
Here’s how to help people impacted by Covid-19
By MARY KEKATOS SENIOR HEALTH REPORTER and NATALIE RAHHAL ACTING US HEALTH EDITOR FOR DAILYMAIL.COM
PUBLISHED: 23:21 BST, 4 May 2020 | UPDATED: 03:38 BST, 5 May 2020
https://www.dailymail.co.uk/health/article-82...month.html
(0)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼